Using UALCAN, we further examined protein expression levels of SLCO1B1, SLCO1B3, and SLCO2B1 in normal liver tissues from healthy individuals and cancer liver tissues from HCC patients, based on data from the CPTAC dataset. Here, SLCO2B1 is linked to hepatocellular carcinoma.